Imunon Statistics
Total Valuation
Imunon has a market cap or net worth of $12.64 million. The enterprise value is $4.34 million.
| Market Cap | 12.64M |
| Enterprise Value | 4.34M |
Important Dates
The last earnings date was Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Imunon has 9.40 million shares outstanding. The number of shares has increased by 13.50% in one year.
| Shares Outstanding | 9.40M |
| Shares Change (YoY) | +13.50% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 4.20% |
| Float | 9.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.51 |
| Quick Ratio | n/a |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -541.76 |
Financial Efficiency
Return on equity (ROE) is -122.70% and return on invested capital (ROIC) is -203.40%.
| Return on Equity (ROE) | -122.70% |
| Return on Assets (ROA) | -84.10% |
| Return on Capital (ROIC) | -203.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$571,307 |
| Employee Count | 33 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.07% in the last 52 weeks. The beta is 2.04, so Imunon's price volatility has been higher than the market average.
| Beta (1Y) | 2.04 |
| 52-Week Price Change | -0.07% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 50.15 |
| Average Volume (30 Days) | 222,765 |
Short Selling Information
The latest short interest is 367,164, so 3.91% of the outstanding shares have been sold short.
| Short Interest | 367,164 |
| Short Previous Month | 463,392 |
| Short % of Shares Out | 3.91% |
| Short % of Float | 3.96% |
| Short Ratio (days to cover) | 1.94 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.36M |
| Pretax Income | -20.13M |
| Net Income | -18.85M |
| EBITDA | -19.39M |
| EBIT | -20.10M |
| Earnings Per Share (EPS) | -$2.02 |
Balance Sheet
The company has $9.81 million in cash and $1.51 million in debt, giving a net cash position of $8.30 million or $0.88 per share.
| Cash & Cash Equivalents | 9.81M |
| Total Debt | 1.51M |
| Net Cash | 8.30M |
| Net Cash Per Share | $0.88 |
| Equity / Book Value | 8.50M |
| Book Value Per Share | 0.90 |
| Working Capital | 7.28M |
Cash Flow
In the last 12 months, operating cash flow was -$20.81 million and capital expenditures -$406,372, giving a free cash flow of -$21.22 million.
| Operating Cash Flow | -20.81M |
| Capital Expenditures | -406,372 |
| Free Cash Flow | -21.22M |
| FCF Per Share | -$2.26 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Imunon does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.50% |
| Shareholder Yield | -13.50% |
| Earnings Yield | -149.12% |
| FCF Yield | -167.82% |
Analyst Forecast
The average price target for Imunon is $12.00, which is 792.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 792.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Mar 1, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |